Idiopathic pulmonary fibrosis: new insights in its pathogenesis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a unique type of chronic fibrosing lung disease of unknown etiology. The sequence of the pathogenic mechanisms is unknown, but the disease is characterized by epithelial injury and activation, the formation of distinctive subepithelial fibroblast/myofibroblast foci, and excessive extracellular matrix accumulation. These pathological processes usually lead to progressive and irreversible changes in the lung architecture resulting in progressive respiratory insufficiency and an almost universally terminal outcome in a relatively short period of time. While research has largely focused on inflammatory mechanisms for initiating the fibrotic response, recent evidence strongly suggests that disruption of the alveolar epithelium is an underlying pathogenic event. Although treatment to date has proved largely ineffective, this new approach has opened up several promising therapeutic avenues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the 'fibrotic foci' thought to be central to the development of human IPF 49 are a loose meshwork of fibroblasts and matrix with little evidence of an impermeable epithelial barrier.49”
From Asbestos-Derived Reactive Oxygen Species Activate TGF-Β1 (2004) · cites this paper as [49]
Citations
Cites
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Idiopathic Pulmonary Fibrosis: Relationship between Histopathologic Features and Mortality
KING, T. E., SCHWARZ, M. I., BROWN, K., TOOZE, J. A., COLBY, T. V., WALDRON, J. A., FLINT, A., THURLBECK, W., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2001056 · Cited by 628
Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramírez, R., Barrios, R., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 425
Platelet-derived growth factor in idiopathic pulmonary fibrosis.
Antoniades, H. N., Bravo, M. A., Avila, R. E., Galanopoulos, T., Neville-Golden, J., Maxwell, M., & Selman, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114808 · Cited by 384 · cited 1×
“Studies approaching cell localization by immunohistochemistry and in situ hybridization have demonstrated that in IPF lungs, alveolar epithelial cells are the main site of synthesis of platelet-derived growth factor, transforming growth factor beta, tumor necrosis factor alpha, connective tissue growth factor, and end…”
Ramos, C., Montaño, M., Garcı́a-Alvarez, J., Ruiz, V., Uhal, B. D., Selman, M., & Pardo, A. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4333 · Cited by 363
Buerger, H., Otterbach, F., Simon, R., Poremba, C., Diallo, R., Decker, T., Riethdorf, L., Brinkschmidt, C., Dockhorn-Dworniczak, B., & Boecker, W. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199903)187:4<396::aid-path286>3.0.co;2-l · Cited by 328
Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung
Uhal, B. D., Joshi, I., Hughes, W. F., Ramos, C., Pardo, A., & Selman, M. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.6.l1192 · Cited by 296 · cited 1×
“Regarding the former, it has been demonstrated that IPF fibroblasts produce angiotensin peptides able to induce epithelial cell death in vitro, which also probably occurs in vivo[14,15].”
BackgroundRelationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis.
Adamson, I. Y. R., Young, L., & Bowden, D. H. (1988) · Europe PMC (PubMed Central) · Cited by 285
Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis
A, G., Michel, R. P., Stewart, D., Sheppard, M., Hamid, Q., & Corrin, B. (1993) · The Lancet · doi:10.1016/0140-6736(93)90694-c · Cited by 280
Cited by
Habermann, A. C., Gutierrez, A. J., Bui, L. T., Yahn, S. L., Winters, N. I., Calvi, C. L., Peter, L., Chung, M.-I., Taylor, C. J., Jetter, C., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1972 · Cited by 1,129
Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., & Borok, Z. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62351-6 · Cited by 951
The mitophagy pathway and its implications in human diseases
Wang, S., Long, H., Hou, L., Feng, B., Ma, Z., Wu, Y., Zeng, Y., Cai, J., Zhang, D.-W., & Zhao, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01503-7 · Cited by 883
“238 It is featured by increased extracellular matrix deposition, repeated damage to the alveolar epithelium, and ultimate pulmonary fi brosis or even organ death.”
BackgroundDaniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., LIMPER, A. H., & Leof, E. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19603 · Cited by 574
“extent of fibroblastic foci in IPF lungs is an independent predictor of lung function and mortality (41).”
BackgroundEpithelial Origin of Myofibroblasts during Fibrosis in the Lung
Willis, B. C., duBois, R. M., & Borok, Z. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-004tk · Cited by 500
“Recently, there has been a return to the notion proposed by Adamson and colleagues (28) that ongoing AEC injury and retarded wound repair may be central to the pathogenesis of pulmonary fibrosis (3, 4).”
Background
Metadata
- Authors
- Pardo, A., & Selman, M.
- Affiliations
- Universidad Nacional Autónoma de México (MX)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- Corresponding author
- Pardo, Annie
- Venue
- The International Journal of Biochemistry & Cell Biology
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 34
- Issue
- 12
- Pages
- 1534-1538
- ISSN
- 1357-2725 (ISSN-L)
- OpenAlex
- W1998398041
- Cited by
- 140
- References
- 17
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 3 · 2023: 8 · 2022: 6 · 2021: 2 · 2020: 10 · 2019: 6 · 2017: 5 · 2016: 2 · 2015: 4 · 2014: 9 · 2013: 6 · 2012: 7
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The International Journal of Biochemistry & Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, pathogenesis, alveolar epithelial injury, epithelial-mesenchymal crosstalk, extracellular matrix accumulation, pulmonary fibrosis, fibrotic response, therapeutic target
- MeSH terms
- Epithelial Cells, Humans, Inflammation, Pulmonary Fibrosis, Collagenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Idiopathic pulmonary fibrosis: new insights in its pathogenesis. https://app.cochat.ai/papers/10.1016/s1357-2725(02)00091-2
- The paper
- Pardo, A., & Selman, M. (2002). Idiopathic pulmonary fibrosis: new insights in its pathogenesis. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/s1357-2725(02)00091-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.